Send to

Choose Destination
See comment in PubMed Commons below
Curr Atheroscler Rep. 2001 Sep;3(5):399-403.

Hormone replacement therapy for prevention of coronary heart disease: current evidence.

Author information

Divisions of Internal Medicine and Cardiology, Department of Medicine, George Washington University, 2150 Pennsylvania Avenue, NW #4-414, Washington, DC 20037, USA.


Postmenopausal estrogen replacement, with or without progestin therapy, has a generally favorable impact on lipids, improves endothelial function, and has anti-inflammatory and antioxidant effects. These properties should favorably impact coronary risk; indeed, epidemiologic studies have consistently associated hormone replacement therapy with reduced coronary risk. Nonetheless, the Heart & Estrogen/progestin Replacement Study (HERS), a randomized, placebo-controlled, secondary prevention trial of conjugated estrogen with progestin, found no overall reduction in coronary events among women assigned to active hormone treatment. This review explores the role of estrogen replacement among interventions intended to prevent coronary heart disease in the post-HERS era.

[Indexed for MEDLINE]
PubMed Commons home

PubMed Commons

How to join PubMed Commons

    Supplemental Content

    Loading ...
    Support Center